• A. Kishore Babu G.B.N. Institute of Pharmacy, Edulabad, Ghatkesar, R.R.Dist-501301, Telangana, India
  • M. V. Ramana Jawaharlal Nehru Technological University, Kukatpally, Hyderabad-500072, Telangana, India



Risperidone, HPMC, Gelucire, X-ray radiographic studies, In vivo bioavailability studies


Objective: The objective of this research work was to formulate and evaluate the floating drug delivery system containing Risperidone, to improve oral bioavailability by increasing gastric residence time.

Methods: Total fifteen formulations of Risperidone floating tablets were prepared by direct compression method using different grades of HPMC polymers, Gelucire, Polyox and NaHCO3. In vivo radiographic studies were performed in human volunteers by incorporating barium sulphate.

Results: The prepared tablets were characterized and found to exhibit satisfactory physicochemical characteristics. All the prepared batches showed good in vitro buoyancy with low floating lag time. It was observed that the tablets remained buoyant for more than 12h. Optimized formulation (F15) consisting of HPMC K100M, WSR 301, Gelucire 50/13 and NaHCO3, followed diffusion controlled zero-order kinetics and non-fickian transport of the drug. FTIR and DSC studies revealed the absence of any chemical interaction between drug and polymers used. The in vivo radiographic studies revealed that the tablets remained in the stomach for 6h in fasting human volunteers. In vivo bioavailability studies performed in healthy human volunteers and Tmax, Cmax, AUC was calculated and confirmed significant improvement in bioavailability when compared with marketed formulation Respidon 2.

Conclusion: The data obtained thus suggests that floating delivery system of Risperidone can be successfully designed to give controlled drug delivery and improved oral bioavailability.


Download data is not yet available.


Moes AJ. Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 1993;10:143–95.

Chandrashekhar B. floating systems for oral controlled release drug delivery. Int J Appl Pharm 2012;4:1-13.

Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery system. Expert Opin Drug Delivery 2006;3:217-33.

Rouge N, Allemann E, Gex-Fabry M, Balant L, Cole ET, Buri P, et al. Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm Acta Helv 1998;73:81-7.

Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery system. Expert Opin Drug Delivery 2006;3:217-33.

Baumgartner S, Kristi J, Vrecer F, Vodopivec P, Zorko B. Optimization of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm 2000;195:125–35.

Iannuccelli V, Coppi G, Bernabei MT, Cameroni R. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int J Pharm 1998;174:47–54.

Levina M, Rajabi AR. The influence of excipients on drug release from HPMC. J Pharm Sci 2004;93:2746–54.

Bravo SA, Lamas MC, Salomon CJ. Swellable matrices for the controlled release of diclofenac sodium: formulation and in vitro studies. Pharm Dev Technol 2004;9:75–83.

Titusville NJ. In: Physician’s desk reference Risperdal® Tablets. J Plant Interact 2005;59:662-7.

Ascher SH, Faries D, Zhu B, Ernst F, Swartz M. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Chem Phys 2006;67:453.

Devis SS. Formulation strategies for absorption windows. Drug Discovery Today 2005;10:249–57.

Jaison D, Elango K, Sundar Raj V, Dhunmati K, Kousalya M. Design development and evaluation of trilayer swelling gastro retentive tablets of lornoxicam for biphasic release and lansoprazole for immediate release for the treatment of arthritis. Int J Pharma Res Rev 2015;4:11-21.

Romulo Pereira R, Cleverson Gasparetto J, Raquel de Oliveira V. Simultaneous determination of levodopa, carbidopa, entacapone, tolcapone, 3-O-methyldopa and dopamine in human plasma by an HPLC–MS/MS method. Bioanalysis 2015;7:207-20.

Nerurkar J, Jun HW, Price JC. Controlled release matrix tablets of ibuprofen using cellulose eather and carragenen; effect of formulation factors on dissolution rates. Eur J Pharm Biopharm 2005;61:56-68.

Kavitha K, Puneeth KP, Tamizh Mani T. Development and evaluation of rosiglitazone maleate floating tablets using natural gums. Int J PharmTech Res 2010;2:1662-9.

Garg R, Gupta GD. Progress in controlled gastro retentive delivery systems. Trop J Pharm Res 2008;7:1055-66.

Prasanna Kumari J, Ramarao T, Jayaveera KN, Bhikshapathi DVRN, Madhusudan Rao Y. Design and in vivo evaluation of metoprolol tartrate bilayer floating tablets in healthy human volunteers. Int J Drug Delivery 2014;6:14-23.

Dhara P, Jayvadan P. Development and validation of RP-HPLC method for simultaneous estimation of risperidone and trihexyphenidyl hydrochloride in tablet dosage forms. Int J Pharm Sci Rev Res 2010;4:85-8.



How to Cite

Babu, A. K., and M. V. Ramana. “DEVELOPMENT AND IN VIVO EVALUATION OF GASTRORETENTIVE FLOATING TABLETS OF ANTIPSYCHOTIC DRUG RISPERIDONE”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 11, Nov. 2016, pp. 43-52, doi:10.22159/ijpps.2016v8i11.9810.



Original Article(s)